Paracetamol (acetaminophen)

Medicine

Volumn 35, Issue 12, 2007, Pages 643-645

  Vale, Allister ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

hepatic encephalopathy; hyperphosphataemia; hypophosphataemia; INR; N acetylcysteine; pH; plasma creatinine; renal failure

Indexed keywords

ACETYLCYSTEINE; CREATININE; PARACETAMOL;

CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; HUMAN; INGESTION; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER FAILURE; LIVER INJURY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL;

EID: 36348974512     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.09.011     Document Type: Review

References (16)

1. Bessems J.G.M., and Vermeulen N.P.E. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31 (2001) 55-138
2. Dargan P.I., and Jones A.L. Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism? A case against. Drug Saf 25 (2002) 625-632
3. Vale J.A., and Proudfoot A.T. Paracetamol (acetaminophen) poisoning. Lancet 346 (1995) 547-552
4. Jones A.F., Harvey J.M., and Vale J.A. Hypophosphataemia and phosphaturia in paracetamol poisoning. Lancet 2 (1989) 608-609
5. Schmidt L.E., and Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 36 (2002) 659-665
6. Florkowski C.M., Jones A.F., Guy J.M., et al. Retinol binding proteinuria and phosphaturia: markers of paracetamol-induced nephrotoxicity. Ann Clin Biochem 31 (1994) 331-334
7. Jones A.L. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol 36 (1998) 277-285
8. Kerr F., Dawson A., Whyte I.M., et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 45 (2005) 402-408
9. Prescott L. Oral or intravenous N-acetylcysteine for acetaminophen poisoning?. Ann Emerg Med 45 (2005) 409-413
10. Prescott L.F., Illingworth R.N., Critchley J.A.J.H., et al. Intravenous N-acetylcysteine: the treatment of choice in paracetamol poisoning. Br Med J 2 (1979) 1097-1100
11. Buckley N.A., Whyte I.M., O'Connell D.L., and Dawson A.H. Oral or intravenous N- acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?. J Toxicol Clin Toxicol 37 (1999) 759-767
12. Smilkstein M.J., Bronstein A.C., Linden C., et al. Acetaminophen overdose: a 48 hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 20 (1991) 1058-1063
13. Smilkstein M.J., Knapp G.L., Kulig K.W., and Rumack B.H. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 319 (1988) 1557-1562
14. Dawson A.H., Henry D.A., and McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 150 (1989) 329-331
15. Keays R., Harrison P.M., Wendon J.A., et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 303 (1991) 1026-1028
16. O'Grady J.G., Alexander G.J.M., Hayllar K.M., and Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445